CFTR and cystic fibrosis: If results shown here can be confirmed inadditional CF model systems (primary airway epithelial monolayersand CF-related tissue organoids), new agents based on this seriescould be tested as useful pharmacology adjuncts for CF and CFTR-relateddiseases such as chronic pancreatitis, rhinosinusitis, and chronicobstructive pulmonary disease.